Methods to Make Homogenous Antibody Drug Conjugates

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Antibody drug conjugates (ADCs) have rapidly advanced from concept to approved therapeutics within three decades.
• The field is increasingly focused on homogeneous, defined antibody conjugation methods.
• Expanding technologies for modifying both antibody and cytotoxic drug components are driving innovation.

Purpose of the Study:

• To review current and emerging antibody and small molecule chemistries for ADC development.
• To highlight strategies for creating specific and homogeneous ADCs.
• To provide insights into the technological advancements shaping the ADC landscape.

Main Methods:

• Review of existing literature on antibody conjugation techniques.
• Analysis of small molecule chemistries employed in ADC development.
• Exploration of emerging conjugation strategies for homogeneous ADCs.

Main Results:

• Identification of key antibody and small molecule chemistries currently utilized in ADC development.
• Overview of novel approaches being explored for creating defined ADCs.
• Emphasis on the trend towards homogeneous conjugation for improved therapeutic profiles.

Conclusions:

• Homogeneous conjugation is a critical advancement in ADC technology.
• A diverse range of antibody and small molecule chemistries are available and under development.
• Continued innovation in conjugation chemistry is essential for the future of targeted cancer therapeutics.